MDT Shareholders' equity
Shareholders' equity at Medtronic rose to $49.5B in fiscal 2026, from $48.0B in 2025.
Stockholders' equity attributable to the parent, as filed.
SOURCE: us-gaap:StockholdersEquity · EDGAR CompanyFacts · CIK 1613103 · EDGAR ↗ · FY2022–FY2026 · ANNUAL
FY2026$49.5B
FY2025 $48.0B
HIGH$52.6B FY2022
LOW$48.0B FY2025
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Shareholders' equity | Change |
|---|---|---|
| FY2026 | $49.5B | +$1.4B |
| FY2025 | $48.0B | $-2.2B |
| FY2024 | $50.2B | $-1.3B |
| FY2023 | $51.5B | $-1.1B |
| FY2022 | $52.6B | — |
More SAME DATA, OTHER VIEWS
Shareholders' equity across coverage → · MDT company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.